For example, in pancreatic cancer, loss of Smad4 is observed and leads to the switch of TGF-β from a tumor-suppressive to a tumor-promoting pathway through its interaction with E-cadherin, vimentin and beta-catenin10. This evidence concerns the gene TGFB1 and neoplasm.